Genentech

KADCYLA - Cost

Updated as of: July 1st, 2024

HCPCS:

J9354

HCPCS Code Descriptor:

Injection, ado-trastuzumab emtansine, 1 mg

Medicare Payment Limit:

The Kadcyla Medicare Payment Limit is $40.042.

Average Sale Price:

KADCYLA ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The Kadcyla Medicare Co-Insurance percentage is 20%. Kadcyla's Medicare Co-Insurance amount is $8.008

APC Code:

The Kadcyla APC Code is: 9131

APC Payment Limit:

The APC Payment Limit for KADCYLA is available. Login to view.

Kadcyla Cost Information:

KADCYLA, manufactured by Genentech, is aligned to HCPCS J9354. KADCYLA became effective on January 1, 2014 and has two NDCs mapped to J Code: J9354. Since 2016, prices have increased every six months. During this time, AWP and WAC increased by around 35% while ASP rose slightly over 30%.

ACCESS PRICING AND MORE BY REGISTERING

Kadcyla’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Kadcyla’s average wholesale price (AWP) information was last updated on:
January 1, 2023

Kadcyla Cost Graph: